1DelGiudice LA,White GA.The role of tissue factor and tissue factor pathway inhibitor in health and disease states[J].J Vet Emerg Crit Care (San Antonio),2009;19(1):23-9. 被引量：1
3Dahm A,Van Hylckama Vlieg A,Bendz B,et al.Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis[J].Blood,2003;101(11):4387-92. 被引量：1
4Bajaj MS,Birktoft JJ,Steer SA,et al.Structurc and biology of tissue factor pathway inhibitor[J].Thromb Hacmost,2001;86(4):957-72. 被引量：1
5Bajaj MS,Tyson DR,Steer SA,et al.Role of GATA motifs in tissue factor pathway inhibitor gene expression in malignant cells[J].Thromb Res,2001;101(3):203-11. 被引量：1
6Golino P.The inhibitor of the tissue factor:factor VⅡ pathway[J].Thromb Res,2002;106(3):257-65. 被引量：1
7Piro O,Broze GJ Jr.Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding circulation[J].Circulation,2004;110(23):3567-72. 被引量：1
8Lockett JM,Mast AE.Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor[J].Biochemistry,2002; 41(15):4989-97. 被引量：1
9Lu G,Broze GJ Jr,Krishnaswamy S.Formation of factors Ⅸa and Ⅹa by the extrinsic pathway:differential regulation by tissue factor pathway inhibitor and antithrombin Ⅲ[J].J Biol Chem,2004;279(17):17241-9. 被引量：1
10Brodin E,Appelbom H,Osterud B,et al.Regulation of thrombin generation by TFPI in plasma without and with heparin[J].Transl Res,2009;153(3):124-31. 被引量：1
4Moatti D, Haidar B, Fumeron F,et al. A new T-287 C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene[ J ]. Thromb Haemost ,2000,84:244 - 249. 被引量：1
5Moatti D ,Seknadji P, Calaud C ,et al. Polymorphisms of the tissue factor pathway inhibitor(TFPI) gene in patients with acute coronary syndromes and in healthy subjects [ J ]. Arterioscler Thromb Vasc Biol, 1999,19:862 - 869. 被引量：1
6American Thoracic Society. The diagnostic approach to acute venous thromboembolism. Clinic practice guideline [ J ]. Am J Respir Crit Care Med, 1999,160 : 1044 - 1066. 被引量：1
7Schafer AI, Levine MN, Konkle BA,et al. Thrombotic disorder:Diagnosis and treatment[ J ]. Am Soc Hematol,2003:520- 539. 被引量：1
8Lopez JA, Kearon C, Lee AYY. Deep venous thrombosis [ J ]. Am Soc Hematol,2004:439 -456. 被引量：1
9Bajaj MS, Birktofi J J, Steer SA, et al. Structure and biology of tissue factor pathway inhibitor [ J ]. Thromb Haemost, 2001,86 : 959 - 972. 被引量：1
10Miyata T,Sakata T,Kuneda K,et al. C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor ( TFPI ) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis [ J ]. Thromb Haemost, 1998,80 : 345 - 346. 被引量：1
5A. Girolami,M.L. Randi,S. Gavasso,A.M. Lombardi,F. Spiezia.The Occasional Venous Thromboses Seen in Patients with Severe (Homozygous) FXII Deficiency are Probably Due to Associated Risk Factors: A Study of Prevalence in 21 Patients and Review of the Literature[J].Journal of Thrombosis and Thrombolysis.2004(2) 被引量：1
6Rosendaal FR.Venous thrombosis: the role of genes, environment, and behavior[].Hematology.2005 被引量：1
7Ohlin A-K,Norlund L,Mariar RA.Thrombomodulin gene variations and thromboembolic disease[].Thrombosis and Haemostasis.1997 被引量：1
8Davis DL,M osesson M W,Kerlin BA, et al.Fibrinogen Columbus:a novel gamma Gly200Val mutation causing hypofibrinogenemia in a family with associated thrombophilia[].Haematologica.2007 被引量：1
9Lijnen,HR,Soria,J,Soria,C,Collen,D,Caen,JP.Dysfibrinogenemia (Fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation[].Thrombosis and Haemostasis.1984 被引量：1
10MA Crowther,J Roberts,R Roberts,M Johnston,P Stevens,P Skingley,GM Patrassi,MT Sartori,J Hirsh,P Prandoni,JI Weitz,M Gent,JS Ginsberg.Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study[].Thrombosis and Haemostasis.2001 被引量：1
